ArticleFrontiers in immunology2023

A risk score combining co-expression modules related to myeloid cells and alternative splicing associates with response to PD-1/PD-L1 blockade in non-small cell lung cancer.

Yichao Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.